Asymchem Laboratories (Tianjin) Co., Ltd. logo

Asymchem Laboratories (Tianjin) Co., Ltd.

6821.HK

HKSEHealthcareBiotechnology

最新データ

HK$111.1

−HK$8.70 · -7.26%

8月24日 15:55 HKT

6821.HKの企業概要

日中の時刻はHKTです。市場データは遅延する場合があります。

企業プロフィール

会社ウェブサイト

Asymchem Laboratories (Tianjin) Co., Ltd. functions as a Contract Development and Manufacturing Organization (CDMO), offering its services to clients across Mainland China and internationally. The company delivers extensive drug research, development, and manufacturing solutions specifically tailored for pharmaceutical and biotechnology enterprises. Their offerings are comprehensive, covering the entire lifecycle from early clinical stages through to full commercialization, including R&D and cGMP compliant production of advanced intermediates, active pharmaceutical ingredients (APIs), and finished formulations, alongside clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the sale and distribution of medicinal products, and active participation in pharmaceutical science and technology innovation. The company was founded in 1999 and maintains its headquarters in Tianjin, China.

業界
Biotechnology
セクター
Healthcare
本社
CN
最高経営責任者(CEO)
Hao Hong
上場以来
2021年12月10日
従業員
10,617

市場での位置

出来高
172.29万
2.04× 平均
平均出来高
84.52万
1日平均出来高
時価総額
400.83億 HKD
ベータ
0.06
市場参照 1

6821.HKの同業他社

GoAI で研究を続ける

GoAIで6821.HKを調査

research.disclaimer